Effects of Combined Antigrowth Factor Receptor Treatment on In Vitro Growth of Multiple Myeloma

Background: Although passive serotherapy for cancer with monoclonal antibodies is an attractive concept, it has unfortunately had limited efficacy in clinical trials. An alternative approach to passive serotherapy is targeting cell surface growth factor receptors with monoclonal antibodies. With som...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JNCI : Journal of the National Cancer Institute 1994-03, Vol.86 (6), p.450-455
Hauptverfasser:	Taetle, Raymond, Santos, Betty Dos, Ohsugi, Yoshiyuki, Koihihara, Yasuo, Yamada, Yoshiki, Messner, Hans, Dalton, William
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - pharmacology Antineoplastic agents Biological and medical sciences Bone marrow Cell Division - drug effects Cellular biology Humans Immunity (Disease) Immunotherapy Interleukin-6 - pharmacology Medical research Medical sciences Multiple Myeloma - pathology Pharmacology. Drug treatments Receptors, Interleukin - analysis Receptors, Interleukin - immunology Receptors, Interleukin - physiology Receptors, Transferrin - analysis Receptors, Transferrin - immunology Receptors, Transferrin - physiology Tumor Cells, Cultured - drug effects Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!